GENETIC POLYMORPHISM OF CYP3A5 AS A KEY REGULATOR OF PHARMACOKINETICS OF TACROLIMUS IN KIDNEY TRANSPLANT PATIENTS: EVIDENCE IN KAZAKH POPULATION
GENETIC POLYMORPHISM OF CYP3A5 AS A KEY REGULATOR OF PHARMACOKINETICS OF TACROLIMUS IN KIDNEY TRANSPLANT PATIENTS: EVIDENCE IN KAZAKH POPULATION
The article is categorized
Full text
Annotation
Article added by the author
Literature
GENETIC POLYMORPHISM OF CYP3A5 AS A KEY REGULATOR OF PHARMACOKINETICS OF TACROLIMUS IN KIDNEY TRANSPLANT PATIENTS: EVIDENCE IN KAZAKH POPULATION
The article is categorized
Full text
Annotation
Article added by the author
Literature